Charles River Laboratories International, Inc. is a company in the U.S. stock market and it is a holding in 128 U.S.-traded ETFs. CRL has around 5.5M shares in the U.S. ETF market. The largest ETF holder of CRL is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 1.36M shares. Investors may also find of interest that the ETF with the largest allocation to CRL stock is Innovator IBD Breakout Opportunities ETF (BOUT), with a portfolio weight of 5.77%. On average, U.S. ETFs allocate 0.56% of CRL to their portfolios.
Additionally, CRL is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CRL as a holding is the iShares Morningstar Mid-Cap ETF (IMCB), with a return of 536.83%.